{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:29:53Z","timestamp":1773991793313,"version":"3.50.1"},"reference-count":196,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.pharmthera.2006.12.002","type":"journal-article","created":{"date-parts":[[2006,12,30]],"date-time":"2006-12-30T12:07:18Z","timestamp":1167480438000},"page":"107-126","source":"Crossref","is-referenced-by-count":33,"title":["Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy"],"prefix":"10.1016","volume":"114","author":[{"given":"Juan","family":"Tamargo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Vaquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Delp\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2006.12.002_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","article-title":"An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases, and tissue factor in vivo and in vitro","volume":"103","author":"Aikawa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammtion\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"issue":"9 Suppl","key":"10.1016\/j.pharmthera.2006.12.002_bib3","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1046\/j.1540-8167.14.s9.23.x","article-title":"Use of nonantiarrhythmic drugs for prevention of sudden cardiac death","volume":"14","author":"Alberte","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib4","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1378\/chest.128.5.3421","article-title":"Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein","volume":"128","author":"Amar","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0735-1097(03)00497-2","article-title":"Lipid-lowering therapy for prevention of ventricular tachyarrhythmias","volume":"42","author":"Anderson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.amjcard.2004.07.108","article-title":"Frequency of elevation of C-reactive protein in atrial fibrillation","volume":"94","author":"Anderson","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib7","first-page":"353","article-title":"Use of HMG-coenzyme A-reductase inhibitors (statins) and risk reduction of atrial fibrillation after cardiac surgery: results of the SPPAF study: a randomised placebo-controlled trial","volume":"25","author":"Auer","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib8","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Avil\u00e9s","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-5793(94)80308-0","article-title":"Simvastatin-sodium delays cell death of anoxic cardiomyocytes by inhibition of the Na+\/Ca2+ exchanger","volume":"343","author":"Bastiaanse","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/hc3401.095946","article-title":"Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction","volume":"104","author":"Bauersachs","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib11","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.18.11.1671","article-title":"HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages","volume":"18","author":"Bellosta","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib12","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1161\/01.CIR.0000018443.44005.D8","article-title":"Autonomic tone variations before the onset of paroxysmal atrial fibrillation","volume":"105","author":"Bettoni","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib13","doi-asserted-by":"crossref","first-page":"C306","DOI":"10.1152\/ajpcell.1989.257.2.C306","article-title":"Excess membrane cholesterol alters calcium channels in arterial smooth muscle","volume":"257","author":"Bialecki","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF00370875","article-title":"Variations of membrane cholesterol alter the kinetics of Ca2+-dependent K+ channels and membrane fluidity in vascular smooth muscle cells","volume":"415","author":"Bolotina","year":"1989","journal-title":"Pfl\u00fcgers Arch"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0735-1097(02)01985-X","article-title":"Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering","volume":"40","author":"Bonetti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/eurheartj\/ehi645","article-title":"Is atrial fibrillation an inflammatory disorder?","volume":"27","author":"Boos","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1753-4887.1998.tb01680.x","article-title":"Sterol regulatory element binding proteins (SREBPs): controlers of lipid synthesis and cellular uptake","volume":"56","author":"Brown","year":"1998","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib18","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1161\/01.CIR.96.10.3542","article-title":"Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia","volume":"96","author":"Bruins","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.amjcard.2006.04.023","article-title":"A comparative analysis of short- and long-term outcomes after ventricular fibrillation out-of-hospital cardiac arrest in patients with ischemic and nonischemic heart disease","volume":"98","author":"Bunch","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib20","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0735-1097(98)00487-2","article-title":"HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis","volume":"32","author":"Bustos","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib21","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/01.CIR.0000039327.11661.16","article-title":"Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke","volume":"106","author":"Cai","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.RES.86.7.816","article-title":"Nerve sprouting and sudden cardiac death","volume":"86","author":"Cao","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib23","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.CIR.101.16.1960","article-title":"Relationship between regional cardiac hyperinnervation and ventricular arrhythmia","volume":"101","author":"Cao","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00210-003-0834-0","article-title":"Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line","volume":"368","author":"Caouette","year":"2003","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib25","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1161\/hh1801.097644","article-title":"Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation","volume":"89","author":"Carnes","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00232523","article-title":"Attenuation of channel kinetics and conductance by cholesterol: an interpretation using structural stress as a unifying concept","volume":"143","author":"Chang","year":"1995","journal-title":"J Membr Biol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1254\/jphs.93.87","article-title":"Pravastatin prevents arrhythmias induced by coronary artery ischemia\/reperfusion in anesthetized normocholesterolemic rats","volume":"93","author":"Chen","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1520-037X.2004.3117.x","article-title":"Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery","volume":"7","author":"Cheruku","year":"2004","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2125.2003.02060.x","article-title":"Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes","volume":"57","author":"Cheung","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.amjcard.2004.10.017","article-title":"Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0021-9150(99)00052-0","article-title":"Heart rate variability and plasma lipids in men with and without ischaemic heart disease","volume":"145","author":"Christensen","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib33","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib34","first-page":"653","article-title":"Acute ischemic ventricular arrhythmias in pigs with helaed myocardial infarction: comparative effects of ischemia at a distance and ischemia at the border zone","volume":"96","author":"Cinca","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0002-9149(02)02711-X","article-title":"Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction","volume":"90","author":"Colivicchi","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib36","first-page":"S353","article-title":"Effects of statin therapy on the recurrence of persistent atrial fibrillation in patients with essential hypertension: a propensity score-adjusted analysis","volume":"25","author":"Colivicchi","year":"2004","journal-title":"Eur Heart J"},{"issue":"2 Suppl","key":"10.1016\/j.pharmthera.2006.12.002_bib37","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1067\/mhj.2001.109950","article-title":"Updated pathophysiologic concepts in unstable coronary artery disease","volume":"141","author":"Conti","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib38","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"issue":"23 Suppl 1","key":"10.1016\/j.pharmthera.2006.12.002_bib39","first-page":"III39","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib41","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0735-1097(00)00787-7","article-title":"Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients","volume":"36","author":"De Sutter","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib40","series-title":"Late Breaking Clinical Trials. Presented in the Heart Rhythm Society 2006 Annual Scientific Sessions; May 17-20, 2006; Boston, Massachusetts","article-title":"Intensive lipid-lowering therapy and ventricular arrhythmias in patients with coronary artery disease and internal cardioverter defibrillators","author":"De Sutter","year":"2006"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/hc3001.092039","article-title":"Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"104","author":"Dechend","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib43","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ehj.2004.04.025","article-title":"Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation","volume":"25","author":"Dernellis","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib44","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ahj.2005.06.032","article-title":"Effect of C-reactive protein reduction on paroxysmal atrial fibrillation","volume":"150","author":"Dernellis","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib45","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0002-9149(00)01172-3","article-title":"Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting","volume":"86","author":"Dotani","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib46","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib47","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1161\/01.CIR.91.8.2235","article-title":"Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs","volume":"91","author":"Elvan","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.103.1.113","article-title":"Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance","volume":"103","author":"Feron","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cardfail.2005.10.014","article-title":"Statins associated with reduced mortality in patients admitted for congestive heart failure","volume":"12","author":"Folkeringa","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.amjcard.2005.04.029","article-title":"Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality","volume":"96","author":"Fonarow","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/oxfordjournals.eurheartj.a059751","article-title":"Is there an isolated arrhythmogenic right atrial myocarditis?","volume":"11","author":"Fromer","year":"1990","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib52","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","article-title":"Histological substrate of atrial biopsies in patients with lone atrial fibrillation","volume":"96","author":"Frustaci","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib53","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.RES.0000195844.31466.e9","article-title":"Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels","volume":"97","author":"Fukuda","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.104.519876","article-title":"Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report","volume":"112","author":"Fukuta","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib55","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/01.CIR.84.1.368","article-title":"Arrhythmogenic effects of graded coronary blood flow reductions superimposed on prior myocardial infarction in dogs","volume":"84","author":"Furukawa","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib56","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","article-title":"ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.RES.75.1.181","article-title":"Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion","volume":"75","author":"Galis","year":"1994","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2006.12.002_bib58","first-page":"II195","article-title":"The \u2212\u00a0174G\/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?","volume":"108","author":"Gaudino","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/01.RES.69.1.216","article-title":"Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells","volume":"69","author":"Gleason","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib60","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jacc.2006.05.053","article-title":"Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy","volume":"48","author":"Goldberger","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib61","first-page":"452","article-title":"Effects of atorvastatin on hKv1.5 and Kv4.3 potassium currents","volume":"26","author":"G\u00f3mez","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib62","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib63","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.jacc.2004.06.063","article-title":"QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients","volume":"44","author":"Haigney","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib64","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.hrthm.2006.05.010","article-title":"Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction","volume":"3","author":"Hanna","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib65","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0022-2828(80)90098-X","article-title":"Effect of cholesterol depletion on the electrical activity of rat heart myocytes in culture","volume":"12","author":"Hasin","year":"1980","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib66","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/hc0702.104164","article-title":"Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction","volume":"105","author":"Hayashidani","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib67","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1042\/bst0310528","article-title":"Molecular mechanism for inhibition of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase by rosuvastatin","volume":"31","author":"Holdgate","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib68","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jacc.2003.07.049","article-title":"Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure","volume":"43","author":"Horwich","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib198","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2125.1997.00587.x","article-title":"Lipoproteins and cardiovascular reactivity","volume":"44","author":"Howes","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib69","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.19.8.1979","article-title":"Heart rate variability and progression of coronary atherosclerosis","volume":"19","author":"Huikuri","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib70","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.0000034047.70205.97","article-title":"Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation","volume":"106","author":"Indolfi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib71","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib72","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.103.15.1933","article-title":"Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels","volume":"103","author":"Jialal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib74","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00005344-198205000-00018","article-title":"Effects of excess free fatty acids on the electrophysiological properties of ventricular specialized conducting tissue: a comparative study between the sheep and the dog","volume":"4","author":"Karagueuzian","year":"1982","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib75","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1124\/jpet.105.093393","article-title":"Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs","volume":"316","author":"Katchman","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib76","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1291\/hypres.24.573","article-title":"Role of cardiac ATP-sensitive K+ channels induced by HMG CoA reductase inhibitor in ischemic rabbit hearts","volume":"24","author":"Kawabata","year":"2001","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib77","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0167-5273(02)00516-8","article-title":"The effect of statin therapy on ventricular late potentials in acute myocardial infarction","volume":"90","author":"Kayikcioglu","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib78","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.RES.0000183735.09871.61","article-title":"A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation","volume":"97","author":"Kim","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1071-9164(97)90022-1","article-title":"The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease","volume":"3","author":"Kjekshus","year":"1997","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib80","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1010-7940(96)01095-0","article-title":"Role of atrial ischemia in development of atrial fibrillation following coronary artery bypass surgery","volume":"11","author":"Kolvekar","year":"1997","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib81","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0735-1097(02)01827-2","article-title":"Statins and chronic heart failure: do we need a large-scale outcome trial?","volume":"39","author":"Krum","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cardiores.2004.01.018","article-title":"The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model","volume":"62","author":"Kumagai","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib83","doi-asserted-by":"crossref","first-page":"13167","DOI":"10.1016\/S0021-9258(18)37686-5","article-title":"Stimulation of sodium-calcium exchange by cholesterol incorporation into isolated cardiac sarcolemmal vesicles","volume":"263","author":"Kutryk","year":"1988","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2006.12.002_bib84","first-page":"209","article-title":"Dietary fatty acids and myocardial function","volume":"82","author":"Lamers","year":"1987","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib85","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.hco.0000179821.11071.79","article-title":"The clinical significance of endothelial dysfunction","volume":"20","author":"Landmesser","year":"2005","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib87","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0002-9149(01)02095-1","article-title":"Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, noncholesterolemic men","volume":"88","author":"Laufs","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib86","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2165\/00003495-200666020-00002","article-title":"HMG-CoA reductase inhibitors in chronic heart failure","volume":"66","author":"Laufs","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib88","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/00005344-200212000-00007","article-title":"Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin f2alpha formation","volume":"40","author":"Lee","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib89","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.yjmcc.2003.09.009","article-title":"Effects of pravastatin on cardiomyocyte hypertrophy and ventricular vulnerability in normolipidemic rats after myocardial infarction","volume":"35","author":"Lee","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib90","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.atherosclerosis.2004.06.005","article-title":"Effect of pravastatin on left ventricular mass by activation of myocardial KATP channels in hypercholesterolemic rabbits","volume":"176","author":"Lee","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib91","doi-asserted-by":"crossref","first-page":"H1352","DOI":"10.1152\/ajpheart.00527.2003","article-title":"Effect of simvastatin on left ventricular mass in hypercholesterolemic rabbits","volume":"288","author":"Lee","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib92","doi-asserted-by":"crossref","first-page":"H220","DOI":"10.1152\/ajpheart.00417.2004","article-title":"Effect of pravastatin on development of left ventricular hypertrophy in spontaneously hypertensive rats","volume":"289","author":"Lee","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib93","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.100.2.178","article-title":"Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts","volume":"100","author":"Lefer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib94","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1096\/fj.00-0819fje","article-title":"HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury","volume":"15","author":"Lefer","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib95","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib96","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/mol.62.3.602","article-title":"Inhibitory effect of fluvastatin on lysophosphatidylcholine-induced nonselective cation current in guinea pig ventricular myocytes","volume":"62","author":"Li","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib97","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib98","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","article-title":"Current concepts of the pathogenesis of the acute coronary syndromes","volume":"104","author":"Libby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/bmme.1995.1056","article-title":"Cholesterol modulation of transmembrane cation transport systems in human erythrocytes","volume":"56","author":"Lijnen","year":"1995","journal-title":"Biochem Mol Med"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib99","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004872-199401000-00009","article-title":"Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems","volume":"12","author":"Lijnen","year":"1994","journal-title":"J Hypertens"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib101","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.RES.0000072999.51484.92","article-title":"Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits","volume":"92","author":"Liu","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib102","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0006-291X(84)91031-3","article-title":"The cholesterol content of the human erythrocyte influences calcium influx through the channel","volume":"124","author":"Locher","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib103","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","article-title":"Expert consensus document on beta-adrenergic receptor blockers","volume":"25","author":"L\u00f3pez-Send\u00f3n","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib104","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurheartj\/ehi150","article-title":"Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?","volume":"26","author":"Lorenz","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.ATV.0000068646.76823.AE","article-title":"Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages","volume":"23","author":"Luan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib106","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/01.CIR.0000091084.46500.BB","article-title":"Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment","volume":"108","author":"Maack","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib107","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1540-8167.1998.tb00942.x","article-title":"Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation","volume":"9","author":"Maixent","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib108","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.amjcard.2005.07.124","article-title":"Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting","volume":"97","author":"Mar\u00edn","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib109","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9149(00)00692-5","article-title":"Effect of fluvastatin on QT dispersion: a new pleiotropic effect?","volume":"85","author":"Mark","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tips.2003.11.007","article-title":"Targeting of ion channels to membrane microdomains: localization of Kv channels to lipid rafts","volume":"25","author":"Martens","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"21 Suppl 1","key":"10.1016\/j.pharmthera.2006.12.002_bib111","first-page":"II34","article-title":"Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress","volume":"109","author":"Mason","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib112","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/01.CIR.96.9.3215","article-title":"Sudden death in coronary artery disease: acute ischemia versus myocardial substrate","volume":"96","author":"Mehta","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib113","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0735-1097(94)00329-O","article-title":"Right coronary artery stenosis: an indepedent predictor of atrial fibrillation after coronary artery bypass surgery","volume":"25","author":"Mendes","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"1 Suppl 1","key":"10.1016\/j.pharmthera.2006.12.002_bib114","first-page":"S105","article-title":"Use of statins is associated with reduced incidence of atrial fibrillation in patients with left ventricular hypertrophy and left atrial dilatation","volume":"1","author":"Merckx","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.CIR.104.2.174","article-title":"Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation","volume":"104","author":"Mihm","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib116","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0735-1097(03)00498-4","article-title":"Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the antiarrhythmics versus implantable defibrillators (AVID) trial","volume":"42","author":"Mitchell","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib117","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005344-200307000-00018","article-title":"Acute vasodilator effects of HMG-CoA reductase inhibitors: involvement of PI3-kinase\/Akt pathway and Kv channels","volume":"42","author":"Mukai","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib118","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50\u00a0years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib119","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","article-title":"Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy","volume":"108","author":"Node","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib120","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1242\/jcs.02348","article-title":"Targeting of voltage-gated potassium channel isoforms to distinct cell surface microdomains","volume":"118","author":"O'Connell","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib121","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(99)00282-4","article-title":"Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells","volume":"376","author":"Oi","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib122","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0005-2736(84)90086-5","article-title":"Cholesterol effect on enzyme activity of sarcolemmal (Ca2+Mg2+)-ATPase from cardiac muscle","volume":"773","author":"Ortega","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib123","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.amjcard.2005.11.082","article-title":"Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion","volume":"97","author":"Ozaydin","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib124","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1529\/biophysj.105.060459","article-title":"Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation","volume":"88","author":"Pandit","year":"2005","journal-title":"Biophys J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib125","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.106.621763","article-title":"Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study","volume":"114","author":"Patti","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib126","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0021-9150(00)00746-2","article-title":"Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease","volume":"157","author":"Pehlivanidis","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib127","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1161\/01.CIR.0000065601.83526.3E","article-title":"Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E\u2212\/\u2212 mice in vivo","volume":"107","author":"Pelat","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib128","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.81.4.1161","article-title":"Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications","volume":"81","author":"Pfeffer","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib129","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1161\/01.CIR.0000065606.63163.B9","article-title":"Simvastatin normalizes autonomic neural control in experimental heart failure","volume":"107","author":"Pliquett","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-2275(20)31657-6","article-title":"Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes","volume":"42","author":"Pound","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib131","doi-asserted-by":"crossref","first-page":"24D","DOI":"10.1016\/S0002-9149(98)00150-7","article-title":"Can antiarrhythmic drugs survive survival trials?","volume":"81","author":"Pratt","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0079-6107(81)90011-0","article-title":"The fluidity of cell membranes and its regulation","volume":"38","author":"Quinn","year":"1981","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib133","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/oxfordjournals.eurheartj.a015344","article-title":"Heart rate variability as a means of assessing prognosis after acute myocardial infarction. A 3-year follow-up study","volume":"18","author":"Quintana","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib134","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2005.09.008","article-title":"Statin use in heart failure: a cause for concern?","volume":"152","author":"Raina","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib135","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2005.05.086","article-title":"The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes","volume":"46","author":"Ray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib136","first-page":"274","article-title":"Hypercholesterolemia alters vascular functions and gene expression of potassium channels in rat aortic smooth muscle cells","volume":"22","author":"Ren","year":"2001","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib137","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/phrs.2002.0988","article-title":"HMG-CoA reductase inhibitors improve heart rate variability in patients with a previous myocardial infarction","volume":"45","author":"Riahi","year":"2002","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib139","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib138","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib140","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib141","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0021-9150(00)00468-8","article-title":"Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits","volume":"154","author":"Rikitake","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib142","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/S0006-3495(02)75323-X","article-title":"Modulation of endothelial inward-rectifier K+ current by optical isomers of cholesterol","volume":"83","author":"Romanenko","year":"2002","journal-title":"Biophys J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib143","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1172\/JCI26381","article-title":"Mechanisms of sudden cardiac death","volume":"115","author":"Rubart","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib144","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.CIR.101.4.439","article-title":"Activation of mitochondrial ATP-dependent potassium channels by nitric oxide","volume":"101","author":"Sasaki","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib146","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/01.CIR.103.21.2598","article-title":"Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice","volume":"103","author":"Scalia","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib147","first-page":"1383","article-title":"Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib148","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/01.CIR.102.22.2774","article-title":"Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation","volume":"102","author":"Schauerte","year":"2000","journal-title":"Circulation"},{"issue":"21 Suppl 1","key":"10.1016\/j.pharmthera.2006.12.002_bib149","first-page":"II18","article-title":"Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?","volume":"109","author":"Schonbeck","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib150","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: a randomized trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib151","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6107(02)00053-6","article-title":"Physiological and pathophysiological roles of ATP-sensitive K+ channels","volume":"81","author":"Seino","year":"2003","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib152","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00395-003-0391-1","article-title":"Impact of hypercholesterolemia on acidosis-induced coronary microvascular dilation","volume":"98","author":"Shioiri","year":"2003","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib153","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000145163.56529.D1","article-title":"Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs","volume":"110","author":"Shiroshita-Takeshita","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib154","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0735-1097(98)00468-9","article-title":"Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia","volume":"32","author":"Shusterman","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib155","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000058743.15215.03","article-title":"Atrial ischemia promotes atrial fibrillation in dogs","volume":"107","author":"Sinno","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib156","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.amjcard.2003.08.023","article-title":"Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion","volume":"92","author":"Siu","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib157","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI109159","article-title":"Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium","volume":"62","author":"Sobel","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib158","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cardfail.2005.05.011","article-title":"Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure","volume":"11","author":"Sola","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib159","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacc.2005.06.088","article-title":"Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure","volume":"47","author":"Sola","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1527-5299.2002.00717.x","article-title":"Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure","volume":"8","author":"Sorescu","year":"2002","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib161","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.ATV.0000030360.72503.56","article-title":"Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol","volume":"22","author":"Sukhova","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib162","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.103.6.836","article-title":"Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later","volume":"103","author":"Sundstrom","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib163","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0006-2952(98)00341-4","article-title":"Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro","volume":"57","author":"Suzumura","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib164","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/01.CIR.0000089190.95415.9F","article-title":"Biomarkers of vascular disease linking inflammation to endothelial activation, Part I","volume":"108","author":"Szmitko","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib165","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI13350","article-title":"Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy","volume":"108","author":"Takemoto","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib166","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/0929867043456241","article-title":"Phamacological approach in the treatment of atrial fibrillation","volume":"11","author":"Tamargo","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib167","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cardiores.2003.12.026","article-title":"Pharmacology of cardiac potassium channels","volume":"62","author":"Tamargo","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib168","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000070455","article-title":"Pitavastatin inhibits upregulation of intermediate conductance calcium-activated potassium channels and coronary arteriolar remodeling induced by long-term blockade of nitric oxide synthesis","volume":"68","author":"Terata","year":"2003","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib169","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00005344-199907000-00016","article-title":"Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity","volume":"34","author":"Tesfamariam","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib172","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib170","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.RES.0000145047.14691.db","article-title":"What causes sudden death in heart failure?","volume":"95","author":"Tomaselli","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib171","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1540-8167.2003.02462.x","article-title":"Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease","volume":"14","author":"Tomita","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib174","first-page":"187","article-title":"Ion channels, membrane lipids and cholesterol: a role for membrane lipid domains in arterial function","volume":"334","author":"Tulenko","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib173","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.amjcard.2003.12.009","article-title":"Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion","volume":"93","author":"Tveit","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib175","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0735-1097(99)00440-4","article-title":"Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction","volume":"34","author":"Ueda","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib176","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/0002-8703(95)90203-1","article-title":"Heart rate variability profiles in symptomatic coronary artery disease and preserved left ventricular function: relation to ventricular tachycardia and transient myocardial ischemia. Regression Growth Evaluation Statin Study (REGRESS)","volume":"130","author":"Van Boven","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib177","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.CIR.94.7.1503","article-title":"Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group","volume":"94","author":"Van Boven","year":"1996","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2006.12.002_bib178","first-page":"130","article-title":"Efectos de la atorvastatina sobre las corrientes de potasio responsables de la repolarizaci\u00f3n auricular humana, hKv1.5 y Kv4.3","volume":"58","author":"Vaquero","year":"2005","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib179","first-page":"76","article-title":"Effects of simvastatin on cardiac hKv1.5, Kv4.3, and calcium currents","volume":"28","author":"Vaquero","year":"2006","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib180","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0022-2828(92)91864-2","article-title":"Lysophosphatidylcholine-induced Ca2+-overload in isolated cardiomyocytes and effect of cytoprotective drugs","volume":"24","author":"Ver Donck","year":"1992","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib182","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cardfail.2005.06.439","article-title":"Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure","volume":"11","author":"Vrtovec","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib183","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jacc.2005.09.053","article-title":"Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II","volume":"47","author":"Vyas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib184","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.ATV.20.1.61","article-title":"Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation","volume":"20","author":"Wagner","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib186","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1358\/dnp.2002.15.2.840047","article-title":"Improvement of endothelial function by HMG-CoA reductase inhibitors","volume":"15","author":"Wassmann","year":"2002","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib185","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/hq0202.104081","article-title":"Cellular antioxidant effects of atorvastatin in vitro and in vivo","volume":"22","author":"Wassmann","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib187","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.0000103680.61390.16","article-title":"Lipid lowering by pravastatin increases parasympathetic modulation of heart rate: Galpha(i2), a possible molecular marker for parasympathetic responsiveness","volume":"108","author":"Welzig","year":"2003","journal-title":"Circulation"},{"issue":"9 Suppl","key":"10.1016\/j.pharmthera.2006.12.002_bib188","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1046\/j.1540-8167.14.s9.20.x","article-title":"Recent advances in drug therapy for atrial fibrillation","volume":"14","author":"Wijffels","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib189","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0735-1097(97)00537-8","article-title":"Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys","volume":"31","author":"Williams","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib190","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.147.9.1561","article-title":"Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib191","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0022-2828(05)82388-0","article-title":"The effect of hypercholesterolemia on the sodium inward currents in cardiac myocyte","volume":"27","author":"Wu","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib192","first-page":"G693","article-title":"Different relationships between cellular ATP and hepatic uptake among taurocholate, cholate, and organic anions","volume":"264","author":"Yamazaki","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib193","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0300-9084(91)90093-G","article-title":"Modulation of membrane function by cholesterol","volume":"73","author":"Yeagle","year":"1991","journal-title":"Biochimie"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib194","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1021\/bi00417a037","article-title":"Effects of cholesterol on (Na+,K+)-ATPase ATP hydrolyzing activity in bovine kidney","volume":"27","author":"Yeagle","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib195","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/hc0802.104457","article-title":"HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells","volume":"105","author":"Yokoyama","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib196","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.amjcard.2003.08.040","article-title":"Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease","volume":"92","author":"Young-Xu","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2006.12.002_bib197","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","article-title":"Sudden cardiac death","volume":"98","author":"Zipes","year":"1998","journal-title":"Circulation"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725806002051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725806002051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T04:48:40Z","timestamp":1628311720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725806002051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":196,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0163725806002051"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2006.12.002","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}